Doxycycline Alleviates Acute Traumatic Brain Injury by Suppressing Neuroinflammation and Apoptosis in a Mouse Model.

Traumatic brain injury (TBI) is one of the significant causes of death among young people worldwide. Doxycycline (DOX), an antibiotic with anti-inflammatory effects, has not been used as a therapeutic agent to modify the inflammatory response after the traumatic brain injury. In this study, intraperitoneal administration of DOX reduced significantly the acute inflammatory markers like IL-6 and CD3, microglial migration to the damaged area marked with Iba-1, and neuronal apoptosis assessed with TUNEL assay at 72 h after the trauma. The low dose, 10 mg/kg of DOX had a dominant anti-inflammatory effect; while the high dose, 100 mg/kg of DOX, was more effective in decreasing neuronal apoptosis. In early hours after the head trauma, use of a low dose (10 mg/ kg) of DOX for decreasing the acute form of inflammation followed by a high dose (100 mg/kg) for the antiapoptotic effects particularly in severe head traumas, would be a promising approach to alleviate the brain injury.